Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from CSL ( (AU:CSL) ) is now available.
CSL Limited has updated its previous dividend announcement to include details on currency rates and local currency conversions. This update pertains to the dividend distribution for the six-month period ending June 30, 2025, with a record date of September 10, 2025. The announcement reflects the company’s ongoing commitment to transparency and provides stakeholders with crucial financial information.
The most recent analyst rating on (AU:CSL) stock is a Buy with a A$232.00 price target. To see the full list of analyst forecasts on CSL stock, see the AU:CSL Stock Forecast page.
More about CSL
CSL Limited operates in the biotechnology industry, focusing on the development and delivery of innovative medicines that save lives and protect public health. The company is known for its work in the development of vaccines, blood plasma derivatives, and other biopharmaceutical products.
Average Trading Volume: 1,032,570
Technical Sentiment Signal: Sell
Current Market Cap: A$102.3B
See more insights into CSL stock on TipRanks’ Stock Analysis page.